210 related articles for article (PubMed ID: 17109215)
21. Soft alkyl ether prodrugs of a model phenolic drug: the effect of incorporation of ethyleneoxy groups on transdermal delivery.
Thomas JD; Majumdar S; Sloan KB
Molecules; 2009 Oct; 14(10):4231-45. PubMed ID: 19924060
[TBL] [Abstract][Full Text] [Related]
22. N-Alkyl-N-alkyloxycarbonylaminomethyl (NANAOCAM) prodrugs of carboxylic acid containing drugs.
Majumdar S; Sloan KB
Bioorg Med Chem Lett; 2007 Mar; 17(5):1447-50. PubMed ID: 17196386
[TBL] [Abstract][Full Text] [Related]
23. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies.
Kim BY; Doh HJ; Le TN; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
Int J Pharm; 2005 Apr; 293(1-2):193-202. PubMed ID: 15778057
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in prodrugs as drug delivery systems.
Lin C; Sunkara G; Cannon JB; Ranade V
Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
[TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of alkylcarbonyloxymethyl (ACOM) ethers as novel prodrugs of phenols for topical delivery: ACOM prodrugs of acetaminophen.
Thomas JD; Sloan KB
Int J Pharm; 2008 Jan; 346(1-2):80-8. PubMed ID: 17629641
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery.
Doh HJ; Cho WJ; Yong CS; Choi HG; Kim JS; Lee CH; Kim DD
J Pharm Sci; 2003 May; 92(5):1008-17. PubMed ID: 12712420
[TBL] [Abstract][Full Text] [Related]
27. Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone.
Pillai O; Hamad MO; Crooks PA; Stinchcomb AL
Pharm Res; 2004 Jul; 21(7):1146-52. PubMed ID: 15290853
[TBL] [Abstract][Full Text] [Related]
28. Is prodrug design an approach to increase water solubility?
Sanches BMA; Ferreira EI
Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
[TBL] [Abstract][Full Text] [Related]
29. Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.
Vooturi SK; Kadam RS; Kompella UB
Mol Pharm; 2012 Nov; 9(11):3136-46. PubMed ID: 23003105
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of physicochemical properties, skin permeation and accumulation profiles of salicylic acid amide prodrugs as sunscreen agent.
Yan YD; Sung JH; Lee DW; Kim JS; Jeon EM; Kim DD; Kim DW; Kim JO; Piao MG; Li DX; Yong CS; Choi HG
Int J Pharm; 2011 Oct; 419(1-2):154-60. PubMed ID: 21839822
[TBL] [Abstract][Full Text] [Related]
31. A surrogate for topical delivery in human skin: silicone membranes.
Sloan KB; Synovec J; Ketha H
Ther Deliv; 2013 Feb; 4(2):203-24. PubMed ID: 23343160
[TBL] [Abstract][Full Text] [Related]
32. Dermal and transdermal delivery: prodrugs.
Sloan KB; Devarajan-Ketha H; Wasdo SC
Ther Deliv; 2011 Jan; 2(1):83-105. PubMed ID: 22833927
[TBL] [Abstract][Full Text] [Related]
33. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
J Microencapsul; 2009 Dec; 26(8):734-47. PubMed ID: 19888882
[TBL] [Abstract][Full Text] [Related]
34. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs.
Waranis RP; Sloan KB
J Pharm Sci; 1987 Aug; 76(8):587-95. PubMed ID: 11002816
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
Mäntylä A; Garnier T; Rautio J; Nevalainen T; Vepsälainen J; Koskinen A; Croft SL; Järvinen T
J Med Chem; 2004 Jan; 47(1):188-95. PubMed ID: 14695832
[TBL] [Abstract][Full Text] [Related]
36. Prodrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal delivery.
Majumdar S; Mueller-Spaeth M; Sloan KB
AAPS PharmSciTech; 2012 Sep; 13(3):853-62. PubMed ID: 22648150
[TBL] [Abstract][Full Text] [Related]
37. Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone.
Vaddi HK; Hamad MO; Chen J; Banks SL; Crooks PA; Stinchcomb AL
Pharm Res; 2005 May; 22(5):758-65. PubMed ID: 15906171
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and topical delivery of N-alkyl-N-alkyloxycarbonylaminomethyl prodrugs of a model phenolic drug: acetaminophen.
Majumdar S; Sloan KB
Int J Pharm; 2007 Jun; 337(1-2):48-55. PubMed ID: 17257787
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption.
Moss GP; Gullick DR; Cox PA; Alexander C; Ingram MJ; Smart JD; Pugh WJ
J Pharm Pharmacol; 2006 Feb; 58(2):167-77. PubMed ID: 16451744
[TBL] [Abstract][Full Text] [Related]
40. Molecular size as the main determinant of solute maximum flux across the skin.
Magnusson BM; Anissimov YG; Cross SE; Roberts MS
J Invest Dermatol; 2004 Apr; 122(4):993-9. PubMed ID: 15102090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
